☰

Jamie R. Senft, Ph.D.

Affiliations: 
2004 West Virginia University, Morgantown, WV, United States 
Area:
Genetics, Oncology
Google:
"Jamie Senft"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Sharon Wenger grad student 2004 West Virginia University
 (Characterization of a conserved chromosome breakpoint at 10q21.3 in human and 10B5.1 in mouse: Possible role in cancer.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sasi R, Senft J, Spruill M, et al. (2020) Double Robertsonian translocations in an infertile patient with macrocytic anemia: a case report Molecular Cytogenetics. 13: 1-6
Sayedian F, Senft JR, Spruill MD, et al. (2014) c-MYC Amplification in Acute Myelogenous Leukemia Evolving from Double Minutes (dmins) to Homogeneously Staining Region (hsr). Journal of the Association of Genetic Technologists. 40: 64-7
Jajosky AN, Coad JE, Vos JA, et al. (2014) RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression. Stem Cells Translational Medicine. 3: 836-48
Esan OA, Senft JR, Wenger SL. (2012) Patterns of BCR/ABL Gene Rearrangements in Chronic Myeloid Leukemia with Complex t(9;22) Using Fluorescence In Situ Hybridization (FISH). Journal of the Association of Genetic Technologists. 38: 5-7
Sargent LM, Kashon ML, Hubbs AF, et al. (2012) Abstract 2345: Amplification of mouse chromosome 4 in chemically induced and invasive mouse lung adenocarcinoma Cancer Research. 72: 2345-2345
Sargent LM, Ensell MX, Ostvold AC, et al. (2008) Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains. Toxicology and Applied Pharmacology. 233: 81-91
Senft J, Helfer B, Frisch SM. (2007) Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Research. 67: 11505-9
Wiltshire T, Senft J, Wang Y, et al. (2007) BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven. Molecular Pharmacology. 71: 1051-60
Wang Y, Wiltshire T, Senft J, et al. (2007) Irofulven induces replication-dependent CHK2 activation related to p53 status. Biochemical Pharmacology. 73: 469-80
Wang Y, Wiltshire T, Senft J, et al. (2006) Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven. Molecular Cancer Therapeutics. 5: 3153-61
See more...